Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|2|163-173

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.2, 2015-04, pp. : 163-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low‐dose valganciclovir prophylaxis for cytomegalovirus in intermediate‐risk (R+) renal transplant recipients: Single‐center experience

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytomegalovirus‐negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 30, Iss. 9, 2016-09 ,pp. : 980-985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytomegalovirus infection in high‐risk kidney transplant recipients receiving thymoglobulin induction—a single‐center experience

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 30, Iss. 9, 2016-09 ,pp. : 1159-1164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to: lower‐dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 625-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-04 ,pp. : 230-234

Karger

Access to resources Recommend Favorite